KVUE — Kenvue Inc. — Income statement
From the XBRL facts of the company's SEC filings. USD, millions, except per-share figures. Latest filing read: 2026-10-30.
No longer files reports with the SEC since 2026-11-12 (Form 15-12G). The statement ends with its last report.
Annual · Quarterly | Latest filing · As first reported | Download all statements (Excel)
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | TTM Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Revenues | 14,467.0 | 15,054.0 | 14,950.0 | 15,444.0 | 15,455.0 | 15,124.0 | 15,530.0‡ |
| Total revenues | 14,467.0 | 15,054.0 | 14,950.0 | 15,444.0 | 15,455.0 | 15,124.0 | 15,530.0‡ |
| Cost of revenues | 6,619.0 | 6,635.0 | 6,665.0 | 6,801.0 | 6,496.0 | 6,332.0 | 6,476.0‡ |
| Gross profit | 7,848.0 | 8,419.0 | 8,285.0 | 8,643.0 | 8,959.0 | 8,792.0 | 9,054.0‡ |
| Selling, general and administrative | 4,956.0 | 5,484.0 | 5,633.0 | 6,141.0 | 6,329.0 | 6,088.0 | 6,094.0‡ |
| Other operating expenses, total | 3,871.0‡ | 15.0‡ | (23.0)‡ | (10.0)‡ | 789.0‡ | 290.0‡ | 253.0‡ |
| Operating income (GAAP, as reported) | (979.0) | 2,920.0 | 2,675.0 | 2,512.0 | 1,841.0 | 2,414.0 | 2,707.0‡ |
| Operating income excl. unusual items (S&P method) | (979.0)‡ | 2,920.0‡ | 2,687.0‡ | 2,512.0‡ | 2,604.0‡ | 2,727.0‡ | - |
| Interest expense | - | 0.0 | 0.0 | 250.0 | - | - | - |
| Net interest expenses | - | 0.0‡ | 0.0 | (250.0) | (378.0) | (379.0) | (372.0)‡ |
| Other non-operating income (expenses) | (37.0)‡ | 5.0‡ | 38.0 | 72.0 | 48.0 | 36.0 | 26.0‡ |
| Other items, reconciling to EBT | - | - | (76.0)‡ | (144.0)‡ | (96.0)‡ | (72.0)‡ | (55.0)‡ |
| Asset writedown | - | - | 12.0‡ | 0.0‡ | 578.0‡ | 23.0‡ | 23.0‡ |
| Gain (loss) on sale of investments | - | - | 1.0 | (7.0) | (72.0) | 0.0 | - |
| Total unusual items | - | - | (11.0)‡ | (7.0)‡ | (835.0)‡ | (313.0)‡ | (272.0)‡ |
| EBT excl. unusual items | (1,016.0)‡ | 2,925.0‡ | 2,648.0‡ | 2,197.0‡ | 2,250.0‡ | 2,312.0‡ | 2,578.0‡ |
| EBT incl. unusual items | (1,016.0) | 2,925.0 | 2,637.0 | 2,190.0 | 1,415.0 | 1,999.0 | 2,306.0‡ |
| Income tax expense | (137.0) | 847.0 | 573.0 | 526.0 | 385.0 | 529.0 | 616.0‡ |
| Earnings from continuing operations | (879.0)‡ | 2,078.0‡ | 2,064.0‡ | 1,664.0‡ | 1,030.0‡ | 1,470.0‡ | 1,690.0‡ |
| Net income | (879.0) | 2,078.0 | 2,064.0 | 1,664.0 | 1,030.0 | 1,470.0 | 1,690.0‡ |
| NI to common incl. extra items | (879.0)‡ | 2,078.0‡ | 2,064.0‡ | 1,664.0‡ | 1,030.0‡ | 1,470.0‡ | 1,690.0‡ |
| NI to common excl. extra items | (879.0)‡ | 2,078.0‡ | 2,064.0‡ | 1,664.0‡ | 1,030.0‡ | 1,470.0‡ | 1,690.0‡ |
| Revenue per share | - | 8.77‡ | 8.71‡ | 8.37‡ | 8.07‡ | 7.89‡ | 8.09‡ |
| Basic EPS | - | 1.21 | 1.20 | 0.90 | 0.54 | 0.77 | 0.88‡ |
| Basic weighted average shares | - | 1,716.2 | 1,716.0 | 1,846.0 | 1,915.0 | 1,917.0 | 1,918.5‡ |
| Diluted EPS | - | 1.21 | 1.20 | 0.90 | 0.54 | 0.76 | 0.88‡ |
| Diluted weighted average shares | - | 1,716.2 | 1,716.0 | 1,850.0 | 1,923.0 | 1,924.0 | 1,922.5‡ |
| Normalized net income (S&P method, 37.5 %) | (635.0)‡ | 1,828.1‡ | 1,655.0‡ | 1,373.1‡ | 1,406.3‡ | 1,445.0‡ | 1,611.3‡ |
| Normalized basic EPS (S&P method) | - | 1.07‡ | 0.96‡ | 0.74‡ | 0.73‡ | 0.75‡ | 0.84‡ |
| Normalized diluted EPS (S&P method) | - | 1.07‡ | 0.96‡ | 0.74‡ | 0.73‡ | 0.75‡ | 0.84‡ |
| EBITDA | (233.0)‡ | 3,651.0‡ | 3,319.0‡ | 3,139.0‡ | 2,463.0‡ | 2,971.0‡ | 3,276.0‡ |
| EBIT | (979.0)‡ | 2,920.0‡ | 2,675.0‡ | 2,512.0‡ | 1,841.0‡ | 2,414.0‡ | 2,707.0‡ |
| Effective tax rate | NM | 29.0%‡ | 21.7%‡ | 24.0%‡ | 27.2%‡ | 26.5%‡ | 26.7%‡ |
‡ derived by arithmetic from reported figures (a fourth quarter is the year less nine months). † read from a substitute line. § reported in a note, not on the face of the statement. “-” not reported. NM not meaningful. Normalized rows follow the S&P method: pre-tax income excluding unusual items, a flat 37.5 % tax rate, less minority interest.
By business segment
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | TTM Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Essential Health | 4,782.0 | 4,870.0 | 4,570.0 | 4,615.0 | 4,688.0 | 4,632.0 | - |
| Self Care | 5,235.0 | 5,643.0 | 6,030.0 | 6,451.0 | 6,527.0 | 6,378.0 | - |
| Skin Health And Beauty | 4,450.0 | 4,541.0 | 4,350.0 | 4,378.0 | 4,240.0 | 4,114.0 | - |
By geography
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | TTM Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Asia Pacific | 3,013.0 | 3,276.0 | 3,146.0 | 3,107.0 | 2,974.0 | 2,775.0 | - |
| EMEA | 3,332.0 | 3,436.0 | 3,188.0 | 3,388.0 | 3,559.0 | 3,721.0 | - |
| Latin America | 1,027.0 | 1,058.0 | 1,198.0 | 1,339.0 | 1,343.0 | 1,369.0 | - |
| North America | 7,095.0 | 7,284.0 | 7,418.0 | 7,610.0 | 7,579.0 | 7,259.0 | - |
| US | 6,357.0 | 6,516.0 | 6,599.0 | 6,767.0 | 6,719.0 | 6,460.0 | - |
Segment figures as the company tagged them in its filings, one breakdown per table; members need not sum to the total.